RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mayer Davidson to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Angiotensin-Converting Enzyme Inhibitors.
Mayer Davidson
Connection Strength
0.212
Angiotensin-Converting Enzyme Inhibitors
  1. Pradhan R, Fong D, March C, Jack R, Rezapour G, Norris K, Davidson MB. Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. J Diabetes Complications. 2002 Nov-Dec; 16(6):377-81.
    View in: PubMed
    Score: 0.212
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support